Identification of therapeutic sensitivities in a spheroid drug combination screen of neurofibromatosis type i associated high grade gliomas

HIGHLIGHTS

• who: Jacquelyn Dougherty et al. from the America, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of have published the research work: Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas, in the Journal: PLOS ONE of October/22,/2022

SUMMARY

Crucially, the mouse lines have never been exposed to serum, are grown in neuronal stem_cell media and express markers consistent with an OPC identity. The mouse glioma cell lines naturally grow as spheres; hence, the mouse drug sensitivity studies were performed . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.